COMT (catechol-O-methyltransferase) is an enzyme that breaks down catecholamines (dopamine, adrenaline) and estrogens. Genetic variants like Val158Met (rs4680) affect enzyme activity. The low-activity Met/Met genotype may lead to higher estrogen levels, which could theoretically influence fertility – e.g., via menstrual cycle regulation or implantation. However, evidence is mixed: some studies link COMT variants to endometriosis or early menopause, others find no association. Environmental factors, hormonal status, and other genes play a larger role. Currently, there is no clinical recommendation to use COMT testing for fertility assessment. The evidence is mostly mechanistic or from small studies. A DNA test alone cannot predict fertility. For fertility concerns, clinical hormone tests (estradiol, progesterone, LH, FSH) and comprehensive evaluation are more appropriate.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-c59c1091eecfa28eb3c5d24c